top of page
All Posts
Why Most Cell Therapy Tech Transfers Slip 4–6 Months — And What Actually Fixes It
The pattern nobody talks about openly Across the 175+ IND programs our team has touched in cell and gene therapies, one pattern shows up repeatedly: the tech transfer slips. Not by a week. By four to six months. The clinical timeline pushes right. The Phase 1 enrollment date moves. The investor update gets a different framing. And nobody — neither the sponsor nor the CDMO — fully owns the slip, because it's not a single failure. It's the accumulation of dozens of small depend
basambarkho
3 days ago6 min read
bottom of page